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Atherosclerosis: Is it Time for a New Name?
To the Editor:
Atherosclerosis, the leading cause of cardiovascular death in
Western countries, is an inflammatory disease.1 Evidence linking
inflammation to atherosclerosis stems from studies focusing on
the acute and chronic phases of coronary heart disease. Elevated
acute-phase reactants and cytokine production, activation of CD4
and CD8 circulating lymphocytes, the presence of infiltrating
macrophages, expression of interferon-g, and neoangiogenesis
all support the notion that atherosclerosis shares similar patho-
physiological mechanisms with other inflammatory/autoimmune
diseases.2 Moreover, the earliest type of atherosclerotic lesion
(the fatty streak) is also an inflammatory lesion, consisting of
macrophages and T-lymphocytes. In addition, circulating mark-
ers of inflammation such as C-reactive protein recently have
been found to be potential predictors of future cardiovascular and
cerebrovascular events in patients with the disease.3,4 The study
reported by Muhlestein et al5 in the October 17, 2000, issue of
Circulation shows that high-sensitivity C-reactive protein can
also be predictive for mortality in patients with coronary artery
disease.
In the light of these recent pathophysiological findings, we
think that time has come to reexamine the name for atheroscle-
rosis and that a new name adapted to a more realistic scientific
language is required. In fact, arteriosclerosis is now seen as a
protective rather than a detrimental mechanism in the evolution
of the disease. Therefore, the undersigned authors propose the
name of inflammatory and sclerosing arterial disease (ISAD),
opening the possibility for other plausible nominations based on
the knowledge of the inflammatory mechanisms of this disease.
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